JP3463000004
JP3463000004
TAKEDA PHARMACEUTICAL CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.33T EUR | 8.14T EUR | 9.3T EUR | 7.64T EUR |
Enterprise Value | 14.31T EUR | 12.62T EUR | 13.59T EUR | 11.84T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | 35.34x |
Forward P/E | 41.62x | -- | -- | -- |
Price to Sales | 2.02x | 1.76x | 2.06x | 2.24x |
Price to Book | 1.22x | 1.08x | 1.25x | 1x |
EV/Revenue | 3.1x | 2.73x | 3.02x | 3.47x |
EV/EBITDA | 11.45x | 19.56x | 19.49x | 10.26x |
Price to FCF (P/FCF) | 17.24x | 16.73x | 19.12x | 16.03x |
EV/FCF | 26.43x | 25.93x | 27.92x | 24.84x |
FCF Yield | 5.8% | 5.98% | 5.23% | 6.24% |